Browsing: Pharma

In addition to the newly approved lung disease drug Brin Supplement, which InsMed expects to…

Novartis is the latest multinational drug manufacturer to prepare to ramp up its research and…

Watch out, Johnson & Johnson. Dizar has reported positive Phase 3 results for oral Zegflovy,…

Since its introduction nine months ago, the FDA’s National Priority Voucher Testing Program has drawn…

Medical, legal, and regulatory (MLR) review processes are under strain as pharmaceutical companies face pressure…

The situation at the CDC’s vaccine advisory committee was further thrown into turmoil this week…

As patents for Novo Nordisk’s popular diabetes and obesity drugs Ozempic and Wigovy expire today…

Rhythm Pharmaceuticals is accelerating the development of Imcivree, a melanocortin 4 receptor (MC4R) agonist. First…

Facing patent cliffs threatening billions in revenue, pharma leaders must embrace 2026 trends in AI drug discovery, biopharma manufacturing, clinical pipelines, and FDA approvals to drive innovation.

China has approved the world’s first commercial brain-computer interface. AstraZeneca is building a new cell…